Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations

od Hu, Chen, Dignam, James J.
izdano v JCO Precis Oncol (2019)

Choice and Interpretation of Statistical Tests Used When Competing Risks Are Present

od Dignam, James J., Kocherginsky, Maria N.
Izdano 2008

Multiple imputation methods for nonparametric inference on cumulative incidence with missing cause of failure

od Lee, Minjung, Dignam, James J., Han, Junhee
Izdano 2014

Prevention of colorectal cancer and dietary management

od Hou, Ningqi, Huo, Dezheng, Dignam, James J.
izdano v Chin Clin Oncol (2013)

Flexible modeling of the hazard rate and treatment effects in long-term survival studies

od Hagar, Yolanda, Dignam, James J, Dukic, Vanja
izdano v Stat Methods Med Res (2017)

The Use and Interpretion of Competing Risks Regression Models

od Dignam, James J., Zhang, Qiang, Kocherginsky, Maria N.
Izdano 2012

Assessing treatment benefit with competing risks not affected by the randomized treatment

od Korn, Edward L., Dignam, James J., Freidlin, Boris
izdano v Stat Med (2014)

Family History of Pancreatic Cancer in a High-Risk Cancer Clinic: Implications for Risk Assessment

od Hall, Michael J., Dignam, James J., Olopade, Olufunmilayo I.
izdano v J Genet Couns (2008)

Bayesian Approach for Flexible Modeling of Semicompeting Risks Data

od Han, Baoguang, Yu, Menggang, Dignam, James J., Rathouz, Paul J.
izdano v Stat Med (2014)

Diffusing capacity predicts long-term survival after lung resection for cancer(†)

od Ferguson, Mark K., Dignam, James J., Siddique, Juned, Vigneswaran, Wickii T., Celauro, Amy D.
Izdano 2012

Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast Density

od Hou, Ningqi, Hong, Susan, Wang, Wenli, Olopade, Olufunmilayo I., Dignam, James J., Huo, Dezheng
Izdano 2013

Comparison of futility monitoring guidelines using completed phase III oncology trials

od Zhang, Qiang, Freidlin, Boris, Korn, Edward L, Halabi, Susan, Mandrekar, Sumithra, Dignam, James J
izdano v Clin Trials (2016)

Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525

od Wang, Meihua, Dignam, James J., Won, Minhee, Curran, Walter, Mehta, Minesh, Gilbert, Mark R.
izdano v Neuro Oncol (2015)

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor–Positive Early-Stage Breast Cancer

od Dignam, James J., Wieand, Kelly, Johnson, Karen A., Fisher, Bernard, Xu, Lei, Mamounas, Eleftherios P.
izdano v J Natl Cancer Inst (2003)

Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: development and validation

od Sène, Mbéry, Taylor, Jeremy M. G., Dignam, James J., Jacqmin-Gadda, Hélène, Proust-Lima, Cécile
izdano v Stat Methods Med Res (2014)

Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer

od Ferrer, Loïc, Rondeau, Virginie, Dignam, James J., Pickles, Tom, Jacqmin-Gadda, Hélène, Proust-Lima, Cécile
izdano v Stat Med (2016)

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

od Dignam, James J., Dukic, Vanja M., Anderson, Stewart J., Mamounas, Eleftherios P., Wickerham, D. Lawrence, Wolmark, Norman
Izdano 2008

Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma

od Labby, Zacariah E., Armato, Samuel G., Kindler, Hedy L., Dignam, James J., Hasani, Arman, Nowak, Anna K.
Izdano 2012

Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma

od Labby, Zacariah E., Armato, Samuel G., Dignam, James J., Straus, Christopher, Kindler, Hedy L., Nowak, Anna K.
Izdano 2013

Integrated phase II/III clinical trials in oncology : A case study

od Wang, Meihua, Dignam, James J, Zhang, Qiang E, DeGroot, John F, Mehta, Minesh P, Hunsberger, Sally
izdano v Clin Trials (2012)